查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600607

臨床微生物學市場：按產品類型、檢體類型、最終用戶、應用分類 - 全球預測 2025-2030

Clinical Microbiology Market by Product (Instruments, Reagents), Specimen Type (Blood, Body fluids, Cerebrospinal Spinal Fluid), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年臨床微生物學市場價值為78億美元，預計到2024年將達到86.8億美元，複合年成長率為10.91%，到2030年將達到161.2億美元。

臨床微生物學的範圍包括引起人類疾病的微生物的研究和應用，例如細菌、病毒、真菌和寄生蟲。這一需求源於日益成長的公共衛生問題、抗生素抗藥性以及對快速診斷和治療解決方案的需求。主要應用是診斷、感染預防和控制以及抗菌藥物敏感性測試，服務於醫院、診斷實驗室和生物技術公司。關鍵的市場成長要素包括分子診斷的進步、感染疾病盛行率的增加以及政府控制疾病傳播的努力。對病原檢測和分類方面的即時檢測和技術創新的需求不斷成長，正在創造巨大的商機。例如，使用電化學和光學生物感測器進行診斷可以提供競爭優勢。然而，新興市場面臨先進診斷技術高成本、缺乏熟練人員以及嚴格法律規範等限制，阻礙了其開發和採用。此外，病原菌的快速突變率對診斷準確性和治療效果的穩定性提出了挑戰。對於相關人員來說，透過投資培訓計劃和追求監管協調來解決這些限制至關重要。創新可以透過增強快速診斷技術、為資源匱乏環境開發經濟實惠的解決方案以及利用巨量資料分析進行預測診斷來推動。基因定序、人工智慧主導的診斷工具和個人化醫療的研究進展為大幅成長提供了途徑。隨著學術界、工業界和醫療機構之間的合作不斷增加，以及推動創新的競爭壓力，市場呈現出動態的特徵。為了確保永續成長和市場滲透，公司正在策略性地投資於研發，強調開拓共用的夥伴關係，並開拓以醫療基礎設施不足但需求不斷成長為特徵的前沿領域。

主要市場統計
基準年[2023] 78億美元
預測年份 [2024] 86.8億美元
預測年份 [2030] 161.2億美元
複合年成長率（%） 10.91%

市場動態：揭示快速發展的臨床微生物學市場的關鍵市場洞察

供需的動態交互作用正在改變臨床微生物學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 增加臨床微生物學在感染疾病管理與控制的應用
    • 促進政府和私人組織在癌症診斷和研究方面的支持和舉措
  • 市場限制因素
    • 缺乏熟練的專業人員、設備和基礎設施
  • 市場機會
    • 臨床微生物學產品和製程的技術進步
    • 照護現場微生物檢測簡介
  • 市場挑戰
    • 臨床微生物實驗室的品質保證與控制問題

波特五力：駕馭臨床微生物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對臨床微生物學市場的外部影響

外部宏觀環境因素在塑造臨床微生物學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床微生物學市場的競爭格局

臨床微生物學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣臨床微生物學市場供應商的績效評估

FPNV定位矩陣是評估臨床微生物學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加臨床微生物學在感染疾病管理與控制的應用
      • 政府和私人組織對癌症診斷和研究的積極支持和努力
    • 抑制因素
      • 缺乏熟練的專業人員、設備和基礎設施
    • 機會
      • 臨床微生物學產品和製程的技術進步
      • 照護現場微生物檢測簡介
    • 任務
      • 臨床微生物實驗室的品質保證與控制問題
  • 市場區隔分析
    • 產品：實驗室設備在臨床微生物學評估中的使用
    • 檢體類型：首選血清樣本進行血清學檢測，以檢測過去或目前的感染情況
    • 最終用戶：在實驗室和實驗室中應用臨床微生物學，提供感染疾病病理學的詳細資訊
    • 應用：識別致病病原體增加了臨床微生物學在胃腸道疾病診斷的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章臨床微生物學市場：依產品

  • 裝置
  • 試劑

第7章臨床微生物學市場標本類型

  • 血
  • 體液
  • 腦脊髓液
  • 屎
  • 唾液
  • 血清
  • 滑液
  • 尿

第8章臨床微生物學市場：依最終使用者分類

  • 學術研究所
  • 醫院和護理提供者
  • 研究所

第9章臨床微生物學市場：依應用分類

  • 自體免疫疾病
  • 心臟病學
  • 糖尿病
  • 藥物測試
  • 消化系統疾病
  • 腎臟病學
  • 腫瘤學
  • 牙周病
  • 呼吸系統疾病
  • 性行為感染傳染病

第10章美洲臨床微生物學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太臨床微生物學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲臨床微生物學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 威奇托州立大學 MDL 實驗室轉向微生物學。
    • 劍橋Start-Ups贏得了開發新診斷方法的資金。
    • 微生物學會與印度班加羅爾科學研究所簽署轉型協議
    • Hardy Diagnostics 與 Premier 簽署手冊微生物學協議
    • 醫學微生物學系推出了四個總價值 680 萬美元的新計劃和一個新網站。
    • ASM 資助包容性微生物學領導計畫。
    • MAESTRIA 是 Biomerieux 開發的新一代微生物學中間件，可最佳化實驗室工作流程並改善患者照護。
    • Beckman Coulter 和 MeMed 將擴大經過驗證的宿主免疫反應診斷的使用範圍，這些診斷可以區分病毒和細菌感染。
    • BD 為微生物實驗室安裝全自動機器人軌道系統。
    • FASTinov 與 Beckman Coulter Life Sciences 合作，將超快 2h-AST 創新技術引入臨床微生物實驗室。
    • 北部計劃開設一個萊姆病和蜱傳疾病的多學科治療中心。
    • Bio-Rad 擴大了 Abbott 診斷平台的品質控制覆蓋範圍。
    • 聯邦資金將增強亞伯達大學應對高傳染性病原體的能力。
    • 牛津大學獲得 1.22 億英鎊（1.3663 億美元）的醫療保健研究資金。
    • Sci-Tech Daresbury 旗下的 Perfectus Biomed Group 已被醫療設備測試領域的全球領導者 NAMSA 收購。
    • HORIBA Veterinary 為難以診斷的寄生蟲增加了新的快速 PCR 檢測。
    • ValitaCell 加入貝克曼庫爾特生命科學公司。
    • Global Access Diagnostics 從 Bio-Rad Laboratories 獲得了 IT-LEISH 快速診斷測試的製造權。
    • SSI Diagnostica 持續強勁成長。
    • BD 和 Accelerate Diagnostics 宣佈建立全球商業合作夥伴關係。
    • SGS 在亞利桑那州鳳凰城開設了一個新的微生物實驗室。
    • 以色列：歐盟向以色列微生物診斷公司 Pocared 提供 2,200 萬歐元（2,426 萬美元）。
    • DCN Dx 收購微生物檢測產品公司 Biomed Diagnostics。
    • 生物梅里埃透過收購 Specific Diagnostics（創新企業），加強了對抗抗菌素抗藥性的努力。
    • 美國國立衛生研究院 (NIH) 資助新的結核病研究和發展中心。
    • Raue 為 Sonic Healthcare 收購 Diagnosticum Laboratory Group 提供顧問服務。
    • ATCC 宣布與 QIAGEN 建立合作夥伴關係，以擴展其生物資訊資料平台。
    • Hardy Diagnostics 現在提供 BioCode MDx-3000。
    • 默克宣布對其生命科學業務部門進行組織變革，以加強其 CDMO 產品並加速未來成長。
    • COPAN Diagnostics 宣布臨床微生物學人工智慧發展又邁出了重要一步。

公司名單

  • ELITech Group
  • Beckman Coulter, Inc.
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Rapid Micro Biosystems, Inc.
  • Kyokuto Pharmaceutical Industrial Co., Ltd.
  • Hardy Diagnostics
  • SSI Diagnostica A/S
  • QIAGEN NV
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.
  • Liofilchem Srl
  • 3M Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Abbott Laboratories
  • COPAN Diagnostics Inc.
  • Cardinal Health, Inc.
  • Vircell SL
  • TCS Biosciences Ltd.
  • Clinichem Ltd.
  • Advanced Instruments, LLC
  • B. Braun SE
  • Pro Lab Diagnostics Inc.
  • Prestige Diagnostics UK Ltd.
  • Laboratorios Conda, SA
  • Becton, Dickinson and Company
  • Shimadzu Corporation
  • HORIBA, Ltd.
  • Diagnostica Longwood SL
Product Code: MRR-4312A385A416

The Clinical Microbiology Market was valued at USD 7.80 billion in 2023, expected to reach USD 8.68 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 16.12 billion by 2030.

The scope of clinical microbiology encompasses the study and application of microorganisms causing diseases in humans, spanning bacteria, viruses, fungi, and parasites. Its necessity arises from growing public health concerns, antibiotic resistance, and the need for rapid diagnostic and therapeutic solutions. Applications are primarily in diagnostics, infection prevention and control, and antimicrobial susceptibility testing, serving hospitals, diagnostic labs, and biotechnology companies. Key market growth factors include advancements in molecular diagnostics, increased prevalence of infectious diseases, and government initiatives to curb disease spread. The rising demand for point-of-care testing and technological innovation in detecting and categorizing pathogens offers significant opportunities. For instance, leveraging electrochemical and optical biosensors in diagnostics could provide competitive advantages. The market, however, faces limitations such as high costs of advanced diagnostic techniques, a shortage of skilled personnel, and stringent regulatory frameworks that can impede development and rollout. Moreover, the rapid mutation rates of pathogens present challenges for consistent diagnostic accuracy and therapeutic efficacy. It's pivotal for stakeholders to address these limitations by investing in training initiatives and pursuing regulatory harmonization. Innovation can be driven by enhancing rapid diagnostic technologies, developing affordable solutions for low-resource settings, and harnessing big data analytics for predictive diagnostics. Further research into genome sequencing, AI-driven diagnostic tools, and personalized medicine can provide substantive growth avenues. The market exhibits a dynamic nature with increasing collaborative efforts between academia, industry, and healthcare facilities, fostering innovation against a backdrop of competitive pressures. Businesses are recommended to invest strategically in R&D, focus on partnerships for technology sharing, and explore untapped regional markets characterized by inadequate health infrastructure but growing demand, to ensure sustainable growth and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 7.80 billion
Estimated Year [2024] USD 8.68 billion
Forecast Year [2030] USD 16.12 billion
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Microbiology Market

The Clinical Microbiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of clinical microbiology in managing and controlling infectious diseases
    • Favorable government and private organizations support, and initiatives in cancer diagnosis and research
  • Market Restraints
    • Limited availability of skilled professionals, equipment and infrastructure
  • Market Opportunities
    • Technological advancement in clinical microbiology products and processes
    • Introduction of point-of-care microbiology testing
  • Market Challenges
    • Problems concerning quality assurance and management in clinical microbiology laboratories

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Microbiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Microbiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Microbiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Microbiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Microbiology Market

A detailed market share analysis in the Clinical Microbiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Microbiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Microbiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Clinical Microbiology Market, highlighting leading vendors and their innovative profiles. These include ELITech Group, Beckman Coulter, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Rapid Micro Biosystems, Inc., Kyokuto Pharmaceutical Industrial Co., Ltd., Hardy Diagnostics, SSI Diagnostica A/S, QIAGEN N.V., Merck KGaA, F. Hoffmann-La Roche Ltd., Liofilchem S.r.l., 3M Company, Bio-Rad Laboratories, Inc., bioMerieux S.A., Abbott Laboratories, COPAN Diagnostics Inc., Cardinal Health, Inc., Vircell S.L., TCS Biosciences Ltd., Clinichem Ltd., Advanced Instruments, LLC, B. Braun SE, Pro Lab Diagnostics Inc., Prestige Diagnostics U.K. Ltd., Laboratorios Conda, S.A., Becton, Dickinson and Company, Shimadzu Corporation, HORIBA, Ltd., and Diagnostica Longwood S.L..

Market Segmentation & Coverage

This research report categorizes the Clinical Microbiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Reagents.
  • Based on Specimen Type, market is studied across Blood, Body fluids, Cerebrospinal Spinal Fluid, Fecal, Saliva, Serum, Synovial Fluid, and Urine.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Care Providers, and Laboratories.
  • Based on Application, market is studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, Gastrointestinal Diseases, Nephrology, Oncology, Periodontal Diseases, Respiratory Diseases, and Sexually Transmitted Diseases.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of clinical microbiology in managing and controlling infectious diseases
      • 5.1.1.2. Favorable government and private organizations support, and initiatives in cancer diagnosis and research
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals, equipment and infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in clinical microbiology products and processes
      • 5.1.3.2. Introduction of point-of-care microbiology testing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems concerning quality assurance and management in clinical microbiology laboratories
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Use of laboratory instruments in clinical microbiology assessments
    • 5.2.2. Specimen Type: Preference for serum samples in serological testing to detect past or current infections
    • 5.2.3. End-User: Adoption of clinical microbiology in laboratories and research institutes to provide detailed insights about infectious disease conditions
    • 5.2.4. Application: Increasing use of clinical microbiology to diagnose gastrointestinal (GI) diseases by identifying causative pathogens
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Microbiology Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents

7. Clinical Microbiology Market, by Specimen Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Body fluids
  • 7.4. Cerebrospinal Spinal Fluid
  • 7.5. Fecal
  • 7.6. Saliva
  • 7.7. Serum
  • 7.8. Synovial Fluid
  • 7.9. Urine

8. Clinical Microbiology Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Hospitals & Care Providers
  • 8.4. Laboratories

9. Clinical Microbiology Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Diseases
  • 9.3. Cardiology
  • 9.4. Diabetes
  • 9.5. Drug Testing
  • 9.6. Gastrointestinal Diseases
  • 9.7. Nephrology
  • 9.8. Oncology
  • 9.9. Periodontal Diseases
  • 9.10. Respiratory Diseases
  • 9.11. Sexually Transmitted Diseases

10. Americas Clinical Microbiology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Microbiology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Microbiology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Wichita State's MDL Lab Shifting To Microbiology.
    • 13.3.2. Cambridge Start-Up Won Funding To Develop New Diagnostics.
    • 13.3.3. Transformative Agreement Signed Between The Microbiology Society And Indian Institute Of Science Bangalore
    • 13.3.4. Hardy Diagnostics Awarded Manual Microbiology Agreement With Premier, Inc.
    • 13.3.5. Department of Medical Microbiology Unveils Four New Projects Worth USD 6.8 Million and New Website.
    • 13.3.6. ASM Funded for Inclusive Microbiology Leaders Program.
    • 13.3.7. MAESTRIA, A New Generation Microbiology Middleware Developed by Biomerieux to Optimize Laboratory Workflow and Improve Patient Care.
    • 13.3.8. Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Viral and Bacterial Infections.
    • 13.3.9. BD Introduces Fully Automated Robotic Track System for Microbiology Labs.
    • 13.3.10. FASTinov Collaborates with Beckman Coulter Life Sciences to Bring Ultra-Rapid 2h-AST Disruptive Technology to Clinical Microbiology Laboratories.
    • 13.3.11. Upstate Planned To Launch A Multidisciplinary Lyme And Tick-Borne Disease Treatment Center.
    • 13.3.12. Bio-Rad Expands QC Range for Abbott Diagnostic Platforms.
    • 13.3.13. Federal Funds Set To Boost U of A's Ability To Handle Highly Infectious Pathogens.
    • 13.3.14. Oxford Gets £122m (USD 136.63 Million) Funding for Healthcare Research.
    • 13.3.15. Sci-Tech Daresbury's Perfectus Biomed Group Acquired by Global Medical Device Testing Leader NAMSA.
    • 13.3.16. HORIBA Veterinary Adds New Rapid PCR Test for Difficult to Diagnose Parasite.
    • 13.3.17. ValitaCell Joins Beckman Coulter Life Sciences.
    • 13.3.18. Global Access Diagnostics Acquires Manufacturing Rights for IT-LEISH Rapid Diagnostic Test From Bio-Rad Laboratories.
    • 13.3.19. SSI Diagnostica Continues a Strong Growth Journey.
    • 13.3.20. BD, Accelerate Diagnostics Announce Global Commercial Collaboration.
    • 13.3.21. SGS Launched New Microbiology Laboratory In Phoenix, Arizona.
    • 13.3.22. Israel: EUR 22 Million (Usd 24.26 Million) EU Backing for Israeli Microbiology Diagnostic Player Pocared.
    • 13.3.23. DCN Dx Acquires Microbiological Testing Products Company Biomed Diagnostics.
    • 13.3.24. bioMerieux Strengthens its Commitment to Fight Antimicrobial Resistance with the Acquisition of Specific Diagnostics, An Innovative Company Focusing on Fast AST Solutions.
    • 13.3.25. NIH Funded New Tuberculosis Research Advancement Centers.
    • 13.3.26. Raue Advises Sonic Healthcare on the Acquisition of Diagnosticum Laboratory Group.
    • 13.3.27. ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN.
    • 13.3.28. Hardy Diagnostics Now Offers the BioCode MDx-3000.
    • 13.3.29. Merck Announced Organizational Transformation of Life Science Business Sector To Strengthen Cdmo Offering And Accelerate Future Growth.
    • 13.3.30. COPAN Diagnostics Announces Another Giant Step in the Evolution of Artificial Intelligence in Clinical Microbiology.

Companies Mentioned

  • 1. ELITech Group
  • 2. Beckman Coulter, Inc.
  • 3. Agilent Technologies, Inc.
  • 4. Thermo Fisher Scientific Inc.
  • 5. Rapid Micro Biosystems, Inc.
  • 6. Kyokuto Pharmaceutical Industrial Co., Ltd.
  • 7. Hardy Diagnostics
  • 8. SSI Diagnostica A/S
  • 9. QIAGEN N.V.
  • 10. Merck KGaA
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Liofilchem S.r.l.
  • 13. 3M Company
  • 14. Bio-Rad Laboratories, Inc.
  • 15. bioMerieux S.A.
  • 16. Abbott Laboratories
  • 17. COPAN Diagnostics Inc.
  • 18. Cardinal Health, Inc.
  • 19. Vircell S.L.
  • 20. TCS Biosciences Ltd.
  • 21. Clinichem Ltd.
  • 22. Advanced Instruments, LLC
  • 23. B. Braun SE
  • 24. Pro Lab Diagnostics Inc.
  • 25. Prestige Diagnostics U.K. Ltd.
  • 26. Laboratorios Conda, S.A.
  • 27. Becton, Dickinson and Company
  • 28. Shimadzu Corporation
  • 29. HORIBA, Ltd.
  • 30. Diagnostica Longwood S.L.

LIST OF FIGURES

  • FIGURE 1. CLINICAL MICROBIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL MICROBIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL MICROBIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL MICROBIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY BODY FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CEREBROSPINAL SPINAL FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY FECAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SYNOVIAL FLUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PERIODONTAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CLINICAL MICROBIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM CLINICAL MICROBIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 203. CLINICAL MICROBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023